No black box warning on record for Terbinafine

As of the latest FDA labeling reviewed, Terbinafine (TERBINAFINE HYDROCHLORIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Terbinafine medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Liver failure, sometimes leading to liver transplant or death, has occurred with the use of oral terbinafine. Obtain pretreatment serum transaminases. Prior to initiating treatment and periodically during therapy, assess liver function tests. Discontinue terbinafine tablets if liver injury develops. • Taste disturbance, including taste loss, has been reported with the

No black box warning on record for Terbinafine

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Liver failure, sometimes leading to liver transplant or death, has occurred with the use of oral terbinafine. Obtain pretreatment serum transaminases. Prior to initiating treatment and periodically during therapy, assess liver function tests. Discontinue terbinafine tablets if liver injury develops. • Taste disturbance, including taste loss, has been reported with the

Terbinafine Black Box Warning

No black box warning on record for Terbinafine

Other warnings & precautions

Terbinafine Black Box Warning

No black box warning on record for Terbinafine

Other warnings & precautions